StemCells Inc (NASDAQ:STEM)
| 1.88 Data as of May 23 |  +0.01 / +0.53%Today’s Change | 0.59 Today|||52-Week Range 2.67 | +15.34% Year-to-Date |
Latest STEM News | Press Releases
No recent news for StemCells Inc.
Today’s Trading
| Previous close | 1.87 |
| Today’s open | 1.86 |
| Day’s range | -- - -- |
| Volume | 240,459 |
| Average volume (3 months) | 309,362 |
| Market cap | $72.9M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | +34.00% |
| Earnings growth (this year) | +39.90% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +12.07% |
| P/E ratio | NM |
| Price/Sales | 34.35 |
| Price/Book | 5.02 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ARWRArrowhead Research C... | -0.03 | -1.38% |
| MAXYMaxygen Inc | +0.02 | +0.85% |
| CDXSCodexis Inc | -0.02 | -0.84% |
| PBMDPrima BioMed Ltd | -0.12 | -4.58% |
Data as of 4:00pm ET, 05/23/2013
Financials
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $1.4M |
| Annual profit (last year) | -$28.5M |
| Net profit margin | -2,082.76% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Martin M. McGlynn |
COO, EVP-Research & Development Ann Tsukamoto, PhD |
Corporate headquarters Newark, California |
Forecasts
